| Factor Information | |
|---|---|
| Data ID | 11 |
| Factor | Average number devices attached per observation |
| Description | HAPI prevalence for this pediatric cardiac cohort was 9.7%. |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | diagnosis |
| Objective | hospital-acquired pressure injuries |
| p Value | <0.001 |
| Conclusion | It revealed a 9.7% prevalence of HAPI for this acute care pediatric cardiac population, with 74% related to the use of medical devices. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 31385861 |
| Year | 2019 |
| Title | Hospital-Acquired Pressure Injuries in Children With Congenital Heart Disease: Prevalence and Associated Factors. |
| Sample | ||
|---|---|---|
| Population | Infants, children, youth | |
| Source | observations | |
| Region | Boston, USA | |
| Method | Patients were evaluated for a maximum of eight observations during a 4-week period to identify Braden QD risk and pressure injury development. Stepwise logistic regression was used to explore risk factors associated with hospital-acquired pressure injuries development, accounting for site as a cluster variable using generalized estimating equations. | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | surgery | |
| Group | pediatric cardiac patients with HAPI(Treatment) | pediatric cardiac patients without HAPI(Control) |
| Number | 27 | 252 |
| Age | ＜21 years | N/A |
| Gender (Male: Female) | 140:139 | N/A |
| Marker Level | 11(8-13) | 6(4-10) |
